88 completed, 29 unknown, 13 recruiting, 6 not yet recruiting. 57 Phase 4, 30 Phase 3, 23 Phase 1, 21 Phase 2, 16 Not applicable.
Follow Cilostazol: new trials by email Literature Review of Cilostazol trials Research Report on Cilostazol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cilostazol for Prevention of Recurrent Stroke Trial Cilostazol 100 mg Tablets, Placebo - Stroke Recurrence, Myocardial Infarction | Phase 3 | Not yet recruiting | Stanford University | 2000 | 2026-10-01 | 2026-10-26 |
| CiLostAzol for pReventIon of Recurrent sTroke in Africa Cilostazol 100 mg - Stroke | Phase 3 | Not yet recruiting | Northern California Institute of Research and Education | 1100 | 2026-08-01 | 2026-06-18 |
| Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic Stroke indubufen, aspirin, clopidogrel, cilostazol - Acute Ischemic Stroke | Not yet recruiting | Nanfang Hospital, Southern Medical University | 2000 | 2026-07-01 | 2026-05-22 | |
| Relying on Pharmacotherapy to Improve Motor Gains in Chronic Stroke Survivors Telmisartan, Metformin, Cilostazol - Stroke | Early Phase 1 | Recruiting | Spaulding Rehabilitation Hospital | 50 | 2026-05-18 | 2026-07-14 |
| Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes Cilostazol, Aspirin - Type 2 Diabetes Mellitus (T2DM), Atherosclerosis | Phase 4 | Recruiting | Seoul National University Bundang Hospital | 1200 | 2026-05-06 | 2026-07-22 |
| Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage Cilostazol (Pletal®) 100 mg Tablets, Placebo, Nimodipine group - Aneurysmal Subarachnoid Hemorrhage | Phase 3 | Not yet recruiting | Centre Hospitalier St Anne | 630 | 2025-12-15 | 2025-09-10 |
| Cilostazol for Preventing Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage Cilostazol 100 mg BID, placebo - Aneurysmal Subarachnoid Hemorrhage | Phase 3 | Recruiting | Beijing Tiantan Hospital | 380 | 2025-12-06 | 2026-10-16 |
| Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease Standard therapy, Cilostazol - Fatty Liver | Phase 1 / Phase 2 | Recruiting | Tanta University | 50 | 2025-11-01 | 2025-11-25 |
| Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol Cilostazol, Aspirin, Clopidogrel - Cerebral Small Vessel Disease | Phase 4 | Not yet recruiting | First Affiliated Hospital of Chengdu Medical College | 632 | 2025-09-20 | 2025-09-23 |
| The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis Aspirin, Clopidogrel, Cilostazol - Cerebral Infarction, Stenosis Artery | Phase 4 | Recruiting | Asan Medical Center | 2340 | 2025-07-10 | 2026-03-27 |
| Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study PFO closure using approved PFO closure devices, Surgical PFO closure, Medical management - Ischemic Stroke, Patent Foramen Ovale | Not yet recruiting | National University Hospital, Singapore | 1000 | 2025-07-01 | 2025-05-21 | |
| Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes Cilostazol / Ginko Leaf Dried Ext., Placebo - Type 2 Diabets Mellitus, Cognitive Ability, General | Phase 3 | Recruiting | Seoul National University Bundang Hospital | 80 | 2025-01-01 | 2025-05-25 |
| Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases Clopidogrel, Aspirin, Cilostazol + Isosorbide Mononitrate - Stroke, Ischemic, Small Vessel Cerebrovascular Disease | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 300 | 2024-12-20 | 2025-03-28 | |
| Cilostazol in Parkinson's Disease Cilostazol, Placebo, Standard treatment - Parkinson's Disease | Phase 2 | Unknown | Ain Shams University | 50 | 2024-10-01 | 2024-09-25 |
| Ticagrelor Versus Cilostazol in Ischemic Stroke Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke | Phase 3 | Unknown | Kafrelsheikh University | 900 | 2024-08-30 | 2024-08-20 |
| Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA Ticagrelor 90 MG, Cilostazol 100 MG, Aspirin 75mg - Ischemic Stroke | Phase 3 | Recruiting | Kafrelsheikh University | 900 | 2024-08-10 | 2025-09-18 |
| Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers Best Practice, Cilostazol, Cryocompression Therapy - Cervical Carcinoma, Fallopian Tube Carcinoma | Phase 2 | Recruiting | Emory University | 70 | 2024-08-01 | 2026-08-27 |
| Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds Cilostazol, Aspirin - Cerebral Microbleeds, Stroke | Phase 3 | Recruiting | Zhejiang Provincial People's Hospital | 848 | 2024-07-18 | 2024-07-31 |
| Clopidogrel Versus Cilostazol on Vessels Clopidogrel, Cilostazol - Type 2 Diabetes, Atherosclerosis | Phase 4 | Recruiting | Seoul National University Bundang Hospital | 120 | 2024-04-16 | 2026-05-05 |
| Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke Ticagrelor 90 MG, Cilostazol 100 MG - Ischemic Stroke | Phase 3 | Unknown | Kafrelsheikh University | 580 | 2024-03-30 | 2024-08-20 |
Showing 20 of 144. Sign in to see all of them.
Ischemic Stroke (21) · Peripheral Arterial Disease (16) · Intermittent Claudication (13) · Coronary Artery Disease (9) · Diabetes Mellitus, Type 2 (9) · Cerebral Infarction (8) · Stroke (8) · Cerebral Small Vessel Diseases (7) · Atherosclerosis (5) · Migraine Disorders (5) · Myocardial Infarction (4) · Acute Coronary Syndrome (3) · Cardiovascular Diseases (3) · Cognitive Dysfunction (3) · Peripheral Vascular Diseases (3)
Kafrelsheikh University (9) · Danish Headache Center (6) · Genovate Biotechnology Co., Ltd., (6) · Asan Medical Center (5) · Korea Otsuka Pharmaceutical Co., Ltd. (5) · Otsuka Beijing Research Institute (5) · Seoul National University Bundang Hospital (5) · Gyeongsang National University Hospital (4) · Samsung Medical Center (4) · Seoul National University Hospital (4) · Ain Shams University (3) · National Cheng-Kung University Hospital (3) · Otsuka Pharmaceutical Co., Ltd. (3) · Sadat City University (3) · Shenyang Northern Hospital (3)
South Korea (41) · United States (26) · Egypt (18) · China (17) · Denmark (7) · Japan (7) · Taiwan (4) · Philippines (3) · United Kingdom (3) · Canada (2) · Germany (2) · Greece (2) · Russia (2) · Thailand (2) · Austria (1)
Ting-Hsing Chao, MD (3) · Daniel V Freeland, DO (2) · Dilip K Guha-Ray, M.D. (2) · Hyeon-Cheol Gwon, MD, PhD (2) · Sun U. Kwon, MD, PhD (2) · Bibiana Bielekova, M.D. (1) · Boyd Richards, DO (1) · Byung-Hee Oh, M.D. (1) · Cheol Ho Kim, M.D. (1) · Cheol Young Park, Professor (1) · Chern-En Chiang, M.D., Ph.D. (1) · Christina Kruuse, MD PhD DMSc (1)
PMID 31867054, PMID 18190818, PMID 2375765, PMID 35224730, PMID 35833913, PMID 12807523, PMID 17261652, PMID 20650435, PMID 22007612, PMID 22837373, PMID 23517020, PMID 24957314, PMID 25487817, PMID 27207972, PMID 29778364, PMID 31122494, PMID 10323786, PMID 11009277, PMID 11558482, PMID 11849859, PMID 11914403, PMID 12379573, PMID 12652104, PMID 16286167, PMID 17636626, PMID 17697815, PMID 1830180, PMID 18355656, PMID 18404599, PMID 18456558, PMID 18567918, PMID 18779447, PMID 19060422, PMID 19106084, PMID 19108880, PMID 19220726, PMID 19324253, PMID 19414633, PMID 19506373, PMID 19840579, PMID 19922880, PMID 19967051, PMID 20150545, PMID 20223369, PMID 20350366, PMID 20735821, PMID 20823393, PMID 20833591, PMID 21125444, PMID 21226953
1UG3NS133209-01A1 (1), 2015 (1), 2016 (1), P30CA138292 (1), U01HL077221 (1), U01HL081656 (1)